Cycle outcomes of dual trigger (GnRH agonist+hCG) versus human chorionic gonadotropin trigger alone in POSEDION group 3–4 poor-responders and normo-responders: A prospective randomized study

Gonen, 1990, Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization, J Clin Endocrinol Metab, 71, 918, 10.1210/jcem-71-4-918 Kolibianakis, 2005, A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists, Hum Reprod, 20, 2887, 10.1093/humrep/dei150 Engmann, 2008, Fertil Steril, 89, 84, 10.1016/j.fertnstert.2007.02.002 He, 2022, Effect of GnRH agonist alone or combined with different low-dose HCG on cumulative live birth rate for high responders in GnRH antagonist cycles: a retrospective study, BMC Pregnancy Childbirth, 221, 1 Vlaisavljevi, 2017, Cumulative live birth rate after GnRH agonist trigger and elective cryopreservation of all embryos in high responders, Reprod Biomed Online, 35, 42, 10.1016/j.rbmo.2017.03.017 Orvieto, 2015, Triggering final follicular maturation-hCG, GnRH-agonist or both, when and to whom?, J Ovarian Res, 8, 60, 10.1186/s13048-015-0187-6 Shapiro, 2008, Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization, Fertil Steril, 90, 231, 10.1016/j.fertnstert.2007.06.030 Lin, 2019, Dual trigger with gonadotropin releasing hormone agonist and human chorionic gonadotropin significantly improves live birth rate for women with diminished ovarian reserve, Reprod Biol Endocrinol, 17, 7, 10.1186/s12958-018-0451-x Maged, 2020, Comparative study between single versus dual trigger for poor responders in GnRH antagonist ICSI cycles: a randomized controlled study, Int J Gynaecol Obstet, 152, 395, 10.1002/ijgo.13405 Chern, 2020, Dual-trigger improves the outcome of in vitro fertilization cycles in older patients with diminished ovarian reserve: a retrospective cohort study, PLoS One, 15, 10.1371/journal.pone.0235707 Tulek, 2022, Dual trigger with gonadotropin releasing hormone agonist and human chorionic gonadotropin improves live birth rates in POSEIDON group 3 and 4 expected poor responders, Gynecol Endocrinol, 38, 731, 10.1080/09513590.2022.2101635 Zhang, 2017, Dual trigger of final oocyte maturation in poor ovarian responders undergoing IVF/ICSI cycles, Reprod BioMed Online, 35, 701, 10.1016/j.rbmo.2017.09.002 Eser, 2018, Dual trigger with gonadotropin releasing hormone and human chorionic gonadotropin for poor responders, J Turk Ger Gynecol Assoc, 19, 98, 10.4274/jtgga.2017.0045 Eftekhar, 2018, A comparison of dual triggering (by administration of GnRH agonist plus HCG) versus HCG alone in poor ovarian responders in ART outcomes, Middle East Fertil Soc J, 23, 350, 10.1016/j.mefs.2018.04.011 Lin, 2013, Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles, Fertil Steril, 100, 1296, 10.1016/j.fertnstert.2013.07.1976 Haas, 2020, GnRH agonist and HCG (dual trigger) versus HCG trigger for final follicular maturation: a double-blinded, randomized controlled study, Hum Reprod, 35, 1648, 10.1093/humrep/deaa107 Tülek, 2021, Dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin improves live birth rate for women with expected normal ovarian response in gonadotropin releasing hormone antagonist cycles: retrospective study, JCOG, 31, 89, 10.5336/jcog.2021-86043 Ali, 2020, Dual trigger using recombinant HCG and gonadotropin-releasing hormone agonist improve oocyte maturity and embryo grading for normal responders in GnRH antagonist cycles: randomized controlled trial, J Gynecol Obstet Hum Reprod, 49, 10.1016/j.jogoh.2020.101728 Gurbuz, 2021, Evaluation of dual trigger with combination of gonadotropin‑ releasing hormone agonist and human chorionic gonadotropin in improving oocyte‑ follicle ratio in normo‑ responder patients, Niger J Clin Pract, 24, 1159, 10.4103/njcp.njcp_574_19 Humaidan, 2016, The novel POSEIDON stratification of ‘low prognosis patients in assisted reproductive technology’ and its proposed marker of successful outcome, F1000Res, 5, 2911, 10.12688/f1000research.10382.1 Gardner, 1999, In vitro culture of human blastocyst, 377 Haas, 2019, Does double trigger (GnRH-agonist + hCG) improve outcome in poor responders undergoing IVF-ET cycle? A pilot study, Gynecol Endocrinol, 35, 628, 10.1080/09513590.2019.1576621 Ata, 2012, Array CGH analysis shows that aneuploidy is not related to the number of embryos generated, Reprod Biomed Online, 24, 614, 10.1016/j.rbmo.2012.02.009 Decleer, 2014, Comparison of HCG triggering versus HCG in combination with a GnRH agonist: a prospective randomized controlled trial, Facts Views Vis Ob Gyn, 6, 203 Alleyassin, 2018, Final oocyte maturation with a dual trigger compared to human chorionic gonadotropin trigger in antagonist co-treated cycles: a randomized clinical trial, Middle East Fertil Soc J, 23, 199, 10.1016/j.mefs.2018.01.001